Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	205.13	109.41	176.5	99.81	1.57	0.73
Cash & Short-Term Investments	205.13	109.41	176.5	99.81	1.57	0.73
Cash Growth	32.78%	-38.01%	76.84%	6269.24%	114.89%	-
Other Current Assets	5.37	2.9	2.25	1.04	0.21	0.42
Total Current Assets	210.5	112.31	178.74	100.84	1.78	1.15
Net Property, Plant & Equipment	0.15	0.13	0.09	-	-	-
Long-Term Investments	-	-	-	-	-	139.4
Other Long-Term Assets	2.75	1.51	0.7	-	3.49	-
Total Assets	213.4	113.95	179.53	100.84	5.26	140.55
Accounts Payable	16.32	12.41	19.51	20.3	4.43	0.07
Accrued Expenses	-	-	-	-	-	0.2
Short-Term Debt	-	-	-	-	7.76	-
Other Current Liabilities	-	-	-	-	2.63	-
Total Current Liabilities	16.32	12.41	19.51	20.3	14.82	0.27
Other Long-Term Liabilities	-	-	-	0.99	-	10.08
Total Long-Term Liabilities	-	-	-	0.99	-	10.08
Total Liabilities	16.32	12.41	19.51	21.29	14.82	10.35
Common Stock	0.01	0.01	0.01	0	-	0
Additional Paid-in Capital	472.15	326.08	302.71	162.82	-	-
Retained Earnings	-275.07	-224.55	-155.9	-103.49	-32.06	-9.18
Total Common Shareholders' Equity	197.09	101.54	146.82	59.33	-32.06	-9.18
Minority Interest	-	-	13.2	20.22	22.5	139.38
Shareholders' Equity	197.09	101.54	160.02	79.55	-9.56	130.2
Total Liabilities & Equity	213.4	113.95	179.53	100.84	5.26	140.55
Total Debt	-	0	0	0	7.76	0
Net Cash (Debt)	205.13	109.41	176.5	99.81	-6.19	0.73
Net Cash Growth	32.78%	-38.01%	76.84%	-	-	-
Net Cash Per Share	1.92	1.16	2.35	3.02	-0.45	0.21
Book Value	197.09	101.54	146.82	59.33	-32.06	-9.18
Book Value Per Share	1.84	1.08	1.96	1.79	-2.32	-2.66
Tangible Book Value	197.09	101.54	146.82	59.33	-32.06	-9.18
Tangible Book Value Per Share	1.84	1.08	1.96	1.79	-2.32	-2.66

SEC Filings: 10-K · 10-Q